Therapeutic inertia has been implicated as a significant contributory factor in suboptimal diabetes management. This course explores the phenomenon – defined as the failure to advance or de-intensify therapy when appropriate.
Using practical case studies and international guidelines, this course introduces you to treating people with type 1 or type 2 diabetes before, during and after Ramadan.
An introduction to the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) 2018 consensus report and its 2019 update.
From the physiology of renal glucose absorption to key outcome trials, this course provides a detailed introduction to this class of diabetes drugs.